19/05/2026
💙💛 Huge congratulations to our UCD Researchers, who have just secured more than €8 million in funding under the Research Ireland Frontiers for the Future programme, the highest amount awarded to any institution in this funding round.
Well done to Professor Adam Byrne, Dr Chuanjie Loh, Dr Rory Johnson, Associate Professor Andrew Mitchell, Dr Christopher Shannon, Professor Desmond Tobin, Dr Joseph Byrne and Associate Professor Morgan Fraser.
Supporting ambitious projects spanning antimicrobial resistance, cancer research, quantum technologies and astrophysics, the funding forms part of a national €20 million investment in high-risk, high-reward research initiatives across Ireland.
Of the eight UCD-led projects to receive investment, three will be funded through the Award stream of the programme and five through the Project stream.
Among these is ‘GlycoMetalGuard’, a project led by Dr Joseph Byrne of the UCD School of Chemical and Bioprocess Engineering, which is developing innovative antimicrobial coatings and therapies to prevent hospital-acquired infections associated with medical devices such as catheters and endotracheal tubes.
The research aims to tackle antimicrobial resistance by targeting harmful bacteria with novel sugar-based metal compounds, supporting safer healthcare environments and improved patient outcomes.
Other funded UCD research includes projects exploring new treatments for metabolic dysfunction-associated steatohepatitis (MASH), melanoma biology, quantum simulators, and the life cycles of massive stars.
The Frontiers for the Future Programme supports independent investigators pursuing innovative research over a four- to five-year period across a broad range of disciplines.
The UCD projects awarded funding:
🫁 ‘Defining the role for itaconate and its isomers in lung fibrosis’ | Professor Adam Byrne | €1,089,422
💡‘LIGHT4CARB: Leveraging Visible Light Photocatalysis for Stereoselective Access to Unexplored Carbohydrate Chemical Space’ | Dr Chuanjie Loh | €1,880,731
🧬 RIBOncology: Harnessing cancer genomics for (non-coding) RNA biology and therapeutics’ | Dr Rory Johnson | €1,298,618
⚛️ ‘Nanoelectronic Quantum Simulators’ | Associate Professor Andrew Mitchell | €789,259
🫀 ‘Targeting the Activin Type II Receptor to treat metabolic dysfunction associated steatohepatitis’ | Dr Christopher Shannon | €803,490
🌞 ‘Leveraging the melanoma-protected human hair follicle for insights into the control of pigment cell proliferation and apoptosis relevant to cutaneous melanoma’ | Professor Desmond Tobin | €770,213
🩺 ‘GlycoMetalGuard: Glycoconjugate metal complexes as targeted bacterial therapeutics and protective coatings suitable for medical devices’ | Dr Joseph Byrne | €791,010
🌚 ‘How Massive Stars Die’ | Associate Professor Morgan Fraser | €686,296